| Date | Title | Description |
| 03.04.2024 | SpliSense Announces FDA Clearance of Investigational New Dru... | – Funding secured from CF Foundation and current investors for SPL84 Phase 2 study – – Two additiona... |
| 03.04.2024 | CF Foundation Provides Up to $8.5M to SpliSense to Support a... | The additional funding will support a Phase 2 clinical trial for an inhaled antisense oligonucleotid... |
| 27.03.2024 | Ayala Pharmaceuticals Announces Completion of Sale of AL102 ... | MONMOUTH JUNCTION, N.J., March 26, 2024 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals Inc. (OTCQX: ADXS),... |
| 12.02.2024 | MediWound Reports Positive Results In Head-to-head Compariso... | (RTTNews) – MediWound Ltd. (MDWD) Monday reported positive results from head-to-head comparison anal... |
| 06.02.2024 | Immunome To Acquire AL102, A Phase 3 Asset for the Treatment... | AL102 is a small molecule gamma secretase inhibitor with a differentiated clinical profile BOTHELL, ... |
| 29.10.2023 | Ayala and BioSight complete the Merger between the companies | REHOVOT, Israel & MONMOUTH JUNCTION, N.J., Oct. 19, 2023 (GLOBE NEWSWIRE) — Ayala Pharmaceutical... |
| 10.09.2023 | SpliSense Successfully Completed Phase 1 Study of SPL84, RNA... | New data published in Nucleic Acid Therapeutics demonstrate broad distribution, as well as cell and ... |
| 30.07.2023 | Ayala Pharmaceuticals and Biosight Enter into Definitive Mer... | Upon completion of the merger, the combined company will operate under the name Ayala Pharmaceutical... |
| 24.04.2023 | FDA Approves Gamida Cell’s Cell Therapy for Treating Blood C... | FDA announced on April 17, 2023 the approval of Israel-based cell therapy company Gamida Cell’s Omis... |
| 28.02.2023 | AION Labs Launches AI Startup for De Novo Antibody Design | - |
| 08.02.2023 | Novel Alliance Responds to Big Pharma’s Most Pressing AI/ML ... | At AION Labs, Pfizer, AstraZeneca, Merck KgGA and Teva Pharmaceuticals have partnered with the Israe... |
| 04.02.2023 | MediWound Announces $27.5 Million Registered Direct Offering... | MediWound announced that it has entered into a definitive securities purchase agreement for the sale... |
| 16.01.2023 | Drugging the Undruggable. | There’s a revolution unfolding in cancer therapeutics as researchers learn to harness the immune sys... |
| 27.12.2022 | MediWound Announces Positive Results in U.S. Phase I/II Stud... | The data shows MW005 to be safe and well-tolerated, with patients achieving complete clinical and hi... |
| 01.12.2022 | IBF joins Nectin Therapeutics Series A Round | Nectin Therapeutics Announces Extended Series A Financing to Over $25M and Initiation of Patient Dos... |
| 19.10.2022 | Advaxis and Ayala Pharmaceuticals Enter into Merger Agreemen... | The merger would result in a combined company that will focus predominantly on the development and c... |
| 09.10.2022 | Gamida Cell presented new long term follow-up data and healt... | Gamida Cell (NASDAQ: GMDA), shared new data showing overall survival and disease-free survival of 63... |
| 09.10.2022 | MediWound Announces $30M Raise for Clinical Trials and Produ... | MediWound Ltd. (Nasdaq: MDWD), which has developed and markets a burn treatment compound that is und... |
| 01.10.2022 | Ayala Pharmaceuticals Announced Fast Track Designation Grant... | Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA) announced that the U.S. Food and Drug Administration (FDA... |
| 15.09.2022 | Ayala Pharmaceuticals Presents Positive Interim Data from RI... | Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) announced updated, positive interim results from Part A o... |
| 06.06.2022 | Gamida Cell Completes Rolling Biologics License Application ... | Gamida Cell (NASDAQ: GMDA), announced positive topline results from its Phase 3 clinical study evalu... |
| 27.05.2022 | Biond Biologics Announces First Patients Dosed with BND-22 (... | - |
| 27.05.2022 | Lonza and Israel Biotech Fund Enter A Collaboration Framewor... | - |
| 15.12.2021 | Pharma Two B Announces Positive Topline Results from its Piv... | - |
| 18.11.2021 | Pharma Two B Announces Licensing and Investment Agreement wi... | - |
| 02.11.2021 | Israeli drug developer, Vensica Therapeutics, raises $16m in... | - |
| 14.10.2021 | Merck, Pfizer, AstraZeneca and Teva join forces with Amazon ... | - |
| 06.07.2021 | Advaxis and Biosight Announce Entry into Definitive Merger A... | The Well-Funded ($50M) Combined Company Will Operate as Biosight Therapeutics to Advance Pipeline of... |
| 13.05.2021 | SpliSense Secures $28.5 Million in Series B Financing | Orbimed, Israel Biotech Fund, Biotel Limited, Integra Holdings and the Cystic Fibrosis Foundation pa... |
| 12.01.2021 | Biond Biologics and Sanofi Enter into Global Licensing Agree... | Biond to receive $125 million upfront with more than $1 billion in potential development, regulatory... |
| 28.12.2020 | Israel Biotech Fund is proud to take an active role in this ... | - |
| 02.12.2020 | Biosight Closes $46M Series C Financing to Advance Clinical ... | The round was led by Israel Biotech Fund with participation from new investors, The Phoenix Insuranc... |
| 05.08.2020 | Biosight Granted U.S. FDA Fast Track Designation for BST-236... | BioSight Ltd, a pharmaceutical company developing innovative therapeutics for hematological malignan... |
| 22.07.2020 | Biosight Announces Clinical Trial Collaboration with the Eur... | BioSight Ltd, a pharmaceutical company developing innovative therapeutics for hematological malignan... |
| 02.06.2020 | Biond Bio appoints Jerome Zeldis, M.D., Ph.D., to Board of D... | Biond Biologics appoints Jerome Zeldis, M.D., Ph.D., Former Chief Medical Officer of Celgene and a m... |
| 19.05.2020 | Biosight Strengthens Board of Directors with Appointment of ... | BioSight Ltd, a pharmaceutical company developing innovative therapeutics for hematological malignan... |
| 12.05.2020 | Gamida Cell Announces Positive Topline Data from Phase 3 Cli... | Gamida Cell (NASDAQ: GMDA), announced positive topline results from its Phase 3 clinical study evalu... |
| 08.05.2020 | Ayala Pharmaceuticals Announces Pricing of Initial Public Of... | Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing ... |
| 12.03.2020 | Biosight Raises $19M in Series C Funding led by Israel Biote... | BioSight Ltd, a pharmaceutical company developing innovative therapeutics for hematological malignan... |
| 19.02.2020 | Pharma Two B Appoints David S. Tierney, MD as CEO | Pharma Two B Ltd., a privately held company developing innovative therapeutics based on previously a... |
| 03.10.2019 | Ayala Pharmaceuticals Presents Encouraging Preliminary Safet... | Ayala Pharmaceuticals announced preliminary results from its ongoing Phase 2 ACCURACY study of lead ... |
| 03.06.2019 | Ayala’s ex-BMS drug shows promise in triple-negative breast ... | On the back of the positive preclinical results and the recent $30 million financing round, Ayala is... |
| 29.05.2019 | Novartis powers Notch cancer biotech Ayala to $30M series B | Novartis has powered Ayala Pharmaceuticals to a $30 million series B round. Ayala will use the cash ... |
| 16.05.2019 | Big Year for Israeli Tissue Agnostic Company Ayala | Ayala is looking to lead the way for the country’s burgeoning biotech sector and take its gamma secr... |
| 04.02.2019 | Biond Bio announced the closing of a $17 million Series B fi... | The financing and due diligence were led by Israel Biotech Fund and Harel Insurance & Finance Gr... |
| 04.02.2019 | Ayala entered a license agreement with Novartis | Ayala entered into an option to license agreement with Novartis for its investigational agent AL102 ... |
| 18.12.2017 | Ayala Pharmaceuticals, Founded by Israel Biotech Fund, aMoon... | Israel Biotech Fund identified the opportunity, led the due diligence and syndicated with aMoon and ... |
| 19.06.2017 | Gamida Cell $40MM Financing to support its Phase 3 Trial | Israel Biotech Fund participated in Gamida Cell’s $40MM financing round which shall support the ongo... |
| 03.04.2017 | Israel Biotech Fund Co-Founder and General Partner Recognize... | American Association for Cancer Research (AACR) Bestows 2017 Team Science Award to a Renowned Team o... |
| 27.02.2017 | Israel Biotech Fund invests in Pharma Two B | A $30MM funding round in Pharma Two B was led by Israel Biotech Fund, which syndicated the investmen... |
| 03.06.2016 | Israel Biotech Fund begins investing | Israel Biotech Fund, founded to make investments in the Israeli biotech industry, today selected can... |
| 19.11.2015 | Biogen invests in a newly formed Israeli fund | Biogen invests in a newly formed fund dedicated to investment in Israeli and Israeli related biotech... |